CVS stock slides before the bell as Medicare Advantage rate shock hits insurers
CVS Health shares fell about 9% in premarket trading after CMS announced a 0.09% net average payment increase for 2027 Medicare Advantage plans, far below investor expectations. The agency set a Feb. 25 deadline for comments and will finalize rates by April 6. UnitedHealth and Humana also dropped in after-hours trading. Insurers face pressure as Medicare Advantage remains a key profit source.